GPhA Nabs IMS for Shortage Plan, Hopes to Start Moving Immediately

Generic Line
GPhA has tapped IMS Health to lead its much-anticipated Accelerated Recovery Initiative (ARI), a data-sharing program linking the FDA and regulated industry designed to speed the recovery of critical need drugs in short supply.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00